22350811000001104: Risedronate sodium 35mg tablets (Milpharm Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Risedronate sodium 35mg tablets (Milpharm Ltd)
\UK product\Virtual medicinal product\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Milpharm Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing phosphorus and/or phosphorus compound (product)\Product containing bisphosphonate\Product containing risedronic acid\Product containing only risedronic acid (medicinal product)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Milpharm Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phosphorus and/or phosphorus compound (product)\Product containing bisphosphonate\Product containing risedronic acid\Product containing risedronic acid in oral dose form (medicinal product form)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Milpharm Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing risedronic acid in oral dose form (medicinal product form)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Milpharm Ltd)
\Medicinal product\Product containing bone resorption inhibitor\Product containing bisphosphonate\Product containing risedronic acid\Product containing only risedronic acid (medicinal product)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Milpharm Ltd)
\Medicinal product\Product containing bone resorption inhibitor\Product containing bisphosphonate\Product containing risedronic acid\Product containing risedronic acid in oral dose form (medicinal product form)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Milpharm Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1608551000001118 Risedronate sodium 35mg tablets (Milpharm Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1608561000001115 Risedronate sodium 35mg tablets (Milpharm Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Is a	Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has active ingredient	Risedronate sodium	false	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has specific active ingredient	Risedronate sodium	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet	Has AMP	True	Risedronate sodium 35mg tablets (Milpharm Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1608551000001118	Risedronate sodium 35mg tablets (Milpharm Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1608561000001115	Risedronate sodium 35mg tablets (Milpharm Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module